UBS Group AG

Position in SNY — Sanofi

CIK 1610520 ZURICH, V8

Back to SNY Full portfolio

Position in SNY

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$72,242,233

+$24,840,534 QoQ

Shares Held

1,693,442

+72.1% QoQ

Ownership

0.071%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#32

of 712 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 73% Shared 0% None 27%

Common Shares in SNY Over Time

Shares Held

Position Value (USD)

Derivatives in SNY

reported options exposure · as of Sep 30, 2025

CallValue

$2,426,080

CallShares

51,400

PutValue

$1,543,440

PutShares

32,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

UBS Group AG holds $17,056,271,930 across 20 Drug Manufacturers - General names. SNY ranks #14 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	3,865,931	$4,636,914,000
2	ABBV	AbbVie Inc.	12,845,120	$3,232,345,993
3	JNJ	Johnson & Johnson	11,036,891	$2,803,039,201
4	MRK	Merck & Co., Inc.	13,744,783	$1,766,204,613
5	AMGN	Amgen Inc	3,308,695	$1,198,144,628
6	AZN	Astrazeneca PLC	5,297,462	$1,004,504,738
7	GILD	Gilead Sciences, Inc.	4,503,294	$568,946,162
8	BMY	Bristol Myers Squibb Co	8,876,439	$511,460,413

All Filings in SNY

Export CSV

35 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$72,242,233	1,693,442	+72.1%	Shares	Defined	2026-08-13
2026-03-31	$47,401,699	983,846	-19.5%	Shares	Defined	2026-05-05
2025-12-31	$59,218,263	1,222,003	-2.1%	Shares	Defined	2026-01-29
2025-09-30	$2,426,080	51,400	+71.3%	Call	Defined	2025-11-13
2025-09-30	$58,942,697	1,248,786	+55.9%	Shares	Defined	2025-11-13
2025-09-30	$1,543,440	32,700	+9.0%	Put	Defined	2025-11-13
2025-06-30	$38,695,342	800,980	+3.0%	Shares	Defined	2025-08-14
2025-03-31	$1,663,800	30,000	+200.0%	Put	Defined	2025-05-13
2025-03-31	$43,111,053	777,336	-54.7%	Shares	Defined	2025-05-13
2024-12-31	$82,831,647	1,717,430	+79.8%	Shares	Defined	2025-02-14
2024-09-30	$55,043,045	955,111	+16.1%	Shares	Defined	2024-11-14
2024-09-30	$576,300	10,000	—	Put	Defined	2024-11-14
2024-06-30	$39,906,874	822,483	-19.3%	Shares	Defined	2024-08-14
2024-06-30	$1,455,600	30,000	-48.8%	Call	Defined	2024-08-14
2024-03-31	$49,535,890	1,019,257	+9.1%	Shares	Defined	2024-05-13
2023-12-31	$46,479,397	934,635	+12.5%	Shares	Defined	2024-02-09
2023-09-30	$3,143,304	58,600	-32.6%	Call	Defined	2023-11-09
2023-09-30	$44,567,329	830,860	-2.3%	Shares	Defined	2023-11-09
2023-06-30	$45,846,799	850,590	-1.1%	Shares	Defined	2023-08-11
2023-03-31	$46,794,831	859,883	-27.6%	Shares	Defined	2023-05-12
2022-12-31	$57,552,613	1,188,367	-5.3%	Shares	Defined	2023-02-08
2022-09-30	$47,726,504	1,255,300	+23.9%	Shares	Defined	2022-11-10
2022-09-30	$3,303,938	86,900	-26.9%	Call	Defined	2022-11-10
2022-06-30	$50,698,149	1,013,355	-0.5%	Shares	Defined	2022-08-10
2022-03-31	$52,298,825	1,018,676	-7.5%	Shares	Defined	2022-05-16
2021-12-31	$5,951,880	118,800	+32.0%	Call	Defined	2022-02-14
2021-12-31	$55,145,019	1,100,699	+26.3%	Shares	Defined	2022-02-14
2021-09-30	$42,010,675	871,410	-16.7%	Shares	Defined	2021-11-15
2021-09-30	$4,338,900	90,000	—	Call	Defined	2021-11-15
2021-06-30	$55,104,792	1,046,426	+25.3%	Shares	Defined	2021-08-13
2021-03-31	$41,297,862	834,975	-1.0%	Shares	Defined	2021-05-12
2020-12-31	$40,962,827	843,030	-0.3%	Shares	Defined	2021-02-11
2020-09-30	$42,403,332	845,193	-8.9%	Shares	Defined	2020-11-12
2020-06-30	$47,373,684	927,986	-2.4%	Shares	Defined	2020-07-31
2020-03-31	$41,587,687	951,228	—	Shares	Defined	2020-05-01
No filing history on record for this holder in this stock.